[1]
Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet 2007; 370: 263-71.
[3]
Prey S, Paul C, Bronsard V, et al. Cardiovascular risk factors in patients with plaque psoriasis: A systematic review of epidemiological studies. J Eur Acad Dermatol Venereol 2010; 24(suppl. 2): 23-30.
[4]
Katsiki N, Anagnostis P, Athyros VG, et al. Psoriasis and vascular risk: An update. Curr Pharm Des 2014; 20: 6114-25.
[5]
Lo Gullo A, Rodríguez-Carrio J, Aragona CO, et al. Subclinical impairment of myocardial and endothelial functionality in very early psoriatic and rheumatoid arthritis patients: Association with vitamin D and inflammation. Atherosclerosis 2018; 271: 214-22.
[6]
Dattilo G, Lamari A, Scarano M, et al. Coronary artery disease and psoriasis. Minerva Cardioangiol 2014; 62: 119-21.
[7]
Dattilo G, Borgia F, Guarneri C, et al. Cardiovascular Risk in Psoriasis: Current State of the Art. Curr Vasc Pharmacol 2019; 17: 85-91.
[8]
Imbalzano E, Vatrano M, Mandraffino G, et al. Arterial stiffness as a predictor of recovery of left ventricular systolic function after acute myocardial infarction treated with primary percutaneous coronary intervention. Int J Cardiovasc Imaging 2015; 31: 1545-51.
[9]
Imbalzano E, Casale M, D’Angelo M, et al. Cardiovascular risk and psoriasis: A role in clinical cardiology? Angiology 2015; 66: 101-3.
[10]
Dattilo G, Imbalzano G, Casale M, et al. Psoriasis and cardiovascular risk: Correlation between psoriasis and cardiovascular functional indices. Angiology 2018; 69: 31-7.
[11]
Dattilo G, Imbalzano E, Lamari A, et al. Ischemic heart disease and early diagnosis. Study on the predictive value of 2D strain. Int J Cardiol 2016; 215: 150-6.
[12]
Dattilo G, Lamari A, Zito C, Carerj S, Marte F, Patanè S. 2-Dimensional strain echocardiography and early detection of myocardial ischemia. Int J Cardiol 2010; 145: e6-8.